NCT00006155View on ClinicalTrials.gov

SU5416 and Carboplatin to Treat Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

April 30, 2001

Conditions
Fallopian Tube NeoplasmOvarian CancerPeritoneal Neoplasm
Interventions
DRUG

SU5416 and carboplatin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006155 - SU5416 and Carboplatin to Treat Ovarian Cancer | Biotech Hunter | Biotech Hunter